reiterateAMGNfinnhub
Barclays Reiterates Equal-Weight Rating on Amgen Inc. (AMGN)
Barclays reiterated its Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on August 14, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Barclays reiterated its Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on August 14, 2026.
Read moreWolfe Research analysts downgraded T-Mobile US, Inc. (NASDAQ:TMUS) from Outperform to Peer Perform on August 14, 2026.
Read moreNeedham reiterated its Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) on August 14, 2026.
Read moreB of A Securities reiterated its Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) on August 14, 2026.
Read moreJP Morgan reiterated its Overweight rating on Applied Materials, Inc. (NASDAQ:AMAT) on August 14, 2026.
Read moreB. Riley Securities reiterated its Buy rating on Applied Materials, Inc.
Read moreRBC Capital reiterated its Outperform rating on Applied Materials, Inc. (NASDAQ:AMAT) on August 14, 2026.
Read moreHSBC analysts downgraded Cisco Systems, Inc. (NASDAQ:CSCO) from Buy to Hold on August 14, 2026.
Read moreWells Fargo reiterated its Overweight rating on JPMorgan Chase & Co. (NYSE:JPM) on August 14, 2026.
Read moreJP Morgan reiterated its Overweight rating on CytomX Therapeutics, Inc. (NASDAQ:CTMX) on August 13, 2026.
Read moreWilliam Blair analysts downgraded Accelerant Holdings (NYSE:ARX) from Outperform to Market Perform on August 13, 2026.
Read moreCanaccord Genuity analysts initiated coverage on Kazia Therapeutics Limited (NASDAQ:KZIA) with a rating of Buy on August 13, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Hyperion DeFi, Inc. (NASDAQ:HYPD) on August 13, 2026.
Read moreChardan Capital reiterated its Buy rating on Hyperion DeFi, Inc. (NASDAQ:HYPD) on August 13, 2026.
Read moreLake Street reiterated its Buy rating on Knightscope, Inc. (NASDAQ:KSCP) on August 13, 2026.
Read moreWedbush reiterated its Outperform rating on STAAR Surgical Company (NASDAQ:STAA) on August 13, 2026.
Read moreUBS reiterated its Sell rating on STAAR Surgical Company (NASDAQ:STAA) on August 13, 2026.
Read moreBaird reiterated its Outperform rating on Andersen (NYSE:ANDG) on August 13, 2026.
Read moreTruist Securities reiterated its Buy rating on Andersen (NYSE:ANDG) on August 13, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Andersen (NYSE:ANDG) on August 13, 2026.
Read more